You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jun 8, 2026
Sale
Calculated transaction value
$1.3M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jun 5, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$549.87
Jun 5, 2026
First close after public filing
$553.14
Jun 9, 2026
30-day return after filing
+0.22%
Through Jul 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,366 shares @ $547.85
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000071
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$6.59M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jun 5, 2026 | $948.38K |
| United Therapeutics Corp UTHR | Sale | Jun 5, 2026 | $1.54M |
| United Therapeutics Corp UTHR Current | Sale | Jun 5, 2026 | $1.3M |
| United Therapeutics Corp UTHR | Sale | Jun 5, 2026 | $707.42K |
| United Therapeutics Corp UTHR | Sale | Jun 5, 2026 | $660.83K |
| United Therapeutics Corp UTHR | Sale | Jun 5, 2026 | $53.95K |
| United Therapeutics Corp UTHR | Exercise | Jun 5, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Jun 5, 2026 | $1.39M |